Skip to main content
SpringerLink
Log in

Klinische Relevanz von Glucocorticoid-Rezeptoren für die Behandlung lymphoider Neoplasien

Glucocorticoid receptors and their relevance for the treatment of lymphoid neoplasias

  • Übersicht
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

A generalized view on the mechanism of steroid hormone action is presented with special emphasis on glucocorticoids and their lymphocytolytic effects. The present knowledge on the structure and function of glucocorticoid receptors is reviewed. Following hormone binding, the receptor complex is activated to a form which is able to interact with chromatin or DNA. Several types of receptor mutants have been obtained in an animal cell culture system which allows selection of cell variants. The biochemical analysis of these mutants helped to establish a domain model of receptor structure. The quantitative effect of receptor numbers and hormone activity on lymphocytolysis is described in a cell culture model system and the results are discussed in view of the rational treatment of lymphoid neoplasia with glucocorticoids. The clinical experience with glucocorticoids alone and in combination therapy with cytostatic drugs is summarized. Our special emphasis is on acute lymphoblastic leukemia and malignant lymphoma as patients with these diseases can now be treated with remarkable success rates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  1. Bagley CM, De Vita VT, Berard CW, Canellos GP (1972) Advanced lymphosarcoma-Intensive cyclical combination chemotherapy with cyclophosphamide, vincristine and prednisone. Ann Int Med 76:227–234

    PubMed  Google Scholar 

  2. Ballard PL, Baxter JD, Higgins SJ, Rousseau GG, Tomkins GM (1974) General presence of glucocorticoid receptors in mammalian tissues. Endocrinology 94:998–1002

    PubMed  Google Scholar 

  3. Bloomfield CD, Munck AU, Smith KA (1984) Glucocorticoid receptor levels predict response to treatment in human lymphoma. In: Gurpide E, Calandra R, Levy C, Soto RJ (eds) Hormones and Cancer. AR Liss, New York, pp 223–233

    Google Scholar 

  4. Bourgeois S, Gasson JC (1985) Genetic and epigenetic basis of glucocorticoid resistance in lymphoid cell lines. In: Litwack G (ed) Biochemical Actions of Hormones 12. Academic Press, New York, pp 311–351

    Google Scholar 

  5. Bremer K, Meusers P, Brittinger G (1980) Chemotherapie der Non-Hodgkin-Lymphome. Internist 21:512–528

    PubMed  Google Scholar 

  6. Clark CR (1984) The cellular distribution of steroid hormone receptors: have we got it right? Trends Biochem Sci 9:207–208

    Google Scholar 

  7. Craddock CG (1978) Corticoid-induced lymphopenia, immunosuppression, and body defense. Ann Intern Med 88:564–566

    PubMed  Google Scholar 

  8. Dellweg H-G, Hotz A, Mugele K, Gehring U (1982) Active domains in wild-type and mutant glucocorticoid receptors. EMBO J 1:285–289

    PubMed  Google Scholar 

  9. Dougherty TF (1952) Effects of hormones on lymphatic tissue. Physiol Rev 32:379–401

    PubMed  Google Scholar 

  10. Ehrsson H, Wallin I, Nilsson S-O, Johansson B (1983) Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester. Eur J Clin Pharmacol 24:251–253

    PubMed  Google Scholar 

  11. Fisher RI, DeVitta VT, Hubbard SM, Longo DL, Wesley R, Chabner BA, Young RC (1983) Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of ProMACE and MOPP chemotherapy. Ann Intern Med 98:304–309

    PubMed  Google Scholar 

  12. Gale RP (1979) Advances in the treatment of acute myelogeneous leukemia. New Engl J Med 300:1189–1199

    PubMed  Google Scholar 

  13. Gehring U (1980) Cell genetics of glucocorticoid responsiveness. In: Litwack G (ed) Biochemical Actions of Hormones 7, Academic Press, New York, pp 205–232

    Google Scholar 

  14. Gehring U (1984) Functional domains in wild-type and variant glucocorticoid receptors of lymphoid cells. In: Bresciani F, King RJB, Lippman ME, Namer M, Raynaud J-P (eds) Hormones and Cancer 2, Raven Press, New York, pp 245–254

    Google Scholar 

  15. Gehring U, Hotz A (1983) Photoaffinity labeling and partial proteolysis of wild-type and variant glucocorticoid receptors. Biochemistry 22:4013–4018

    PubMed  Google Scholar 

  16. Gehring U, Arndt H (1985) Heteromeric nature of glucocorticoid receptors. FEBS Letters 179:138–142

    PubMed  Google Scholar 

  17. Gehring U, Ulrich J, Segnitz B (1982) Lymphoma cell variants of decreased glucocorticoid sensitivity. Mol Cell Endocrinol 28:605–611

    PubMed  Google Scholar 

  18. Gehring U, Mugele K, Ulrich J (1984) Cellular receptor levels and glucocorticoid responsiveness of lymphoma cells. Mol Cell Endocrinol 36:107–113

    PubMed  Google Scholar 

  19. Green S, Walter P, Kumar V, Krust A, Bornert J-M, Argos P, Chambon P (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320:134–139

    PubMed  Google Scholar 

  20. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J (1986) Sequence and expression of human estrogen receptor complementary DNA. Science 231:1150–1154

    PubMed  Google Scholar 

  21. Henderson ES (1969) Treatment of acute leukemia. Semin Hematol 6:271–319

    PubMed  Google Scholar 

  22. Higgins SJ, Gehring U (1978) Molecular mechanism of steroid hormone action. Adv Cancer Res 28:313–397

    PubMed  Google Scholar 

  23. Ho AD, Hunstein W, Ganeshaguru K, Hoffbrand AV, Brandeis W, Denk B (1982) Therapeutic and prognostic implications of glucocorticoid receptors and terminal deoxynucleotidyl transferase in acute leukemia. Leukemia Res 6:1–8

    Google Scholar 

  24. Ho AD, Stojakowits S, Pralle H, Dörner M, Hunstein W (1983) Glucocorticoid receptor level, terminal deoxynucleotidyl transferase activity and initial responsiveness to prednisone and vincristine in leukemia. Klin Wochenschr 61:455–459

    PubMed  Google Scholar 

  25. Hoelzer D, Thiel E, Löffler H, Bodenstein H, Plaumann L, Büchner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, Müller U, Wendt F-C, Sodomann H, Rühl H, Herrmann F, Kaboth W, Dietzfelbinger H, Pralle H, Lunscken Ch, Hellriegel K-P, Spors S, Nowrousian RM, Fischer J, Fülle H, Mitrou PS, Pfreundschuh M, Görg Ch, Emmerich B, Queisser W, Meyer P, Labedzki L, Essers U, König H, Mainzer K, Herrmann R, Messerer D, Zwingers T (1984) Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 64:38–47

    PubMed  Google Scholar 

  26. Holbrook NJ, Bodwell JE, Jeffries M, Munck A (1983) Characterization of nonactivated and activated glucocorticoid-receptor complexes from intact rat thymus cells. J Biol Chem 158:6477–6485

    Google Scholar 

  27. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM (1985) Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318:635–641

    PubMed  Google Scholar 

  28. Iacobelli S, Marchetti P, De Rossi G, Mandelli F (1984) Glucocorticoid receptors and steroid sensitivity of human acute lymphoblastic leukemia. In: Gurpide E, Calandra R, Levy C, Soto RJ (eds) Hormones and Cancer. AR Liss, New York, pp 235–246

    Google Scholar 

  29. Jensen EV (1984) Intracellular localization of estrogen receptors: implications for interaction mechanism. Lab Invest 51:487–488

    PubMed  Google Scholar 

  30. Laurence J, Coleman M, Allen SL, Silver RT, Pasmantier M (1982) Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen. Ann Intern Med 97:190–195

    PubMed  Google Scholar 

  31. Lenhard RE Jr, Prentice RL, Owens AH Jr, Bakmeier R, Horton JH, Shnider BI, Stolbach L, Berard CW, Carbone P (1976) Combination chemotherapy of the malignant lymphomas — a controlled clinical trial. Cancer 38:1051–1059

    Google Scholar 

  32. Lippman ME (1979) Glucocorticoid receptors and effects in human lymphoid and leukemic cells. In: Baxter JD, Rousseau GG (eds) Glucocorticoid Hormone Action. Springer, Berlin Heidelberg New York, pp 377–397

    Google Scholar 

  33. Marković RD, Litwack G (1980) Activation of liver and kidney glucocorticoid-receptor complexes occurs in vivo. Arch Biochem Biophys 202:374–379

    PubMed  Google Scholar 

  34. Mattsson W, von Eben F, Turesson I, Wählby S (1978) Prednimustine treatment of lymphocytic and lymphocytic-histiocytic lymphomas. Cancer 41:112–116

    PubMed  Google Scholar 

  35. Medical Research Council (1966) Treatment of acute leukemia in adults: Comparison of steroid and mercaptopurine therapy, alone and in conjunction. Br Med J i:1383–1389

    Google Scholar 

  36. Munck A, Foley R (1979) Activation of steroid hormonereceptor complexes in intact target cells in physiological conditions. Nature 278:752–754

    PubMed  Google Scholar 

  37. Munck A, Crabtree GR (1981) Glucocorticoid-induces lymphocyte death. In: Bowen ID, Lockshin RA (eds) Cell Death in Biology and Pathology, Chapman and Hall, London, pp 329–359

    Google Scholar 

  38. Newell DR, Calvert AH, Harrap KR, McElwain TJ (1983) Studies on the pharmacokinetics of chlorambucil and prednimustine in man. Br J Clin Pharmac 15:253–258

    Google Scholar 

  39. Pedersen-Bjergaard J, Hansen MM, Geisler CH, Nissen NI (1980) Clinical trial of prednimustine, Leo-1031, in patients with non-Hodgkin lymphomata and chronic lymphocytic leukemia previously treated with steroids and alkylating agents. Acta Med Scand 207:215–220

    PubMed  Google Scholar 

  40. Pui C-H, Costlow ME, Dahl GV, Rivera G, Murphy SB (1983) Response of recurrent acute lymphoblastic leukemia to glucocorticoids: serial studies of receptor content, in vivo cytokinetic changes and clinical responses. Leukemia Res 7:747–753

    Google Scholar 

  41. Pui C-H, Ochs J, Kalwinsky KD, Costlow ME (1984) Impact of treatment efficacy on the prognostic value of glucocorticoid receptor levels in childhood acute lymphoblastic leukemia. Leukemia Res 8:345–350

    Google Scholar 

  42. Raaka BM, Samuels HH (1983) The glucocorticoid receptor in GH1 cells. J Biol Chem 258:417–425

    PubMed  Google Scholar 

  43. Ranney H, Gelhorn A (1957) The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas. Ann Int Med 22:405–413

    Google Scholar 

  44. Riehm H, Gardner H, Heinze G, Langermann HJ, Odenwald E (1980) The Berlin childhood acute lymphoblastic leukemia study 1970–1976. Am J Pediat Hematol Oncol 2:299–306

    Google Scholar 

  45. Ringold GM (1985) Steroid hormone regulation of gene expression. Ann Rev Pharmacol Toxicol 25:529–566

    Google Scholar 

  46. Rousseau GG (1984) Structure and regulation of the glucocorticoid hormone receptor. Mol Cell Endocrinol 38:1–11

    PubMed  Google Scholar 

  47. Sherman MR, Stevens J (1984) Structure of mammalian steroid receptors: evolving concepts and methodological developments. Ann Rev Physiol 46:83–105

    Google Scholar 

  48. Stevens J, Stevens Y-W, Haubenstock H (1983) Molecular basis of glucocorticoid resistance in experimental and human leukemia. In: Litwack G (ed) Biochemical Actions of Hormones 10, Academic Press, New York, pp 383–446

    Google Scholar 

  49. Thompson EB, Smith JR, Bourgeois S, Hormon JM (1985) Glucocorticoid receptors in human leukemias and related diseases. Klin Wochenschr 63:689–698

    PubMed  Google Scholar 

  50. Vedeckis WV (1983) Subunit dissociation as a possible mechanism of glucocorticoid receptor activation. Biochemistry 22:1983–1989

    PubMed  Google Scholar 

  51. Vedeckis WV (1985) Steroid hormone receptor structure in normal and neoplastic cells. In: Hollander VP (ed) Hormonally Responsive Tumors, Academic Press, New York

    Google Scholar 

  52. Weinberger C, Hollenberg SM, Rosenfeld MG, Evans RM (1985) Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product. Nature 318:670–672

    PubMed  Google Scholar 

  53. Weinstein HJ, Mayer RJ, Rosenthal DS, Camitta BM, Coral FS, Nathan DG, Frei E III (1980) Treatment of acute myelogenous leukemia in children and adults. New Engl J Med 303:473–478

    PubMed  Google Scholar 

  54. Weinstein HJ, Mayer RJ, Rosenthal DS, Coral FS, Camitta BM, Gelber RD (1983) Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. Blood 62:315–319

    PubMed  Google Scholar 

  55. Westphal HM, Mugele K, Beato M, Gehring U (1984) Immunochemical characterization of wild-type and variant glucocorticoid receptors by monoclonal antibodies. EMBO J 3:1493–1498

    PubMed  Google Scholar 

  56. Zeller WJ, Schreiber J, Ho AD, Schmähl D, Eisenbrand G (1984) Cytostatic activity of steroid linked nitrosoureas. J Cancer Res Clin Oncol 108:164–168

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Biologische Chemie der Universität Heidelberg, Germany

    U. Gehring

  2. Medizinische Universitäts-Poliklinik Heidelberg, Germany

    A. D. Ho

Authors
  1. U. Gehring
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. D. Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gehring, U., Ho, A.D. Klinische Relevanz von Glucocorticoid-Rezeptoren für die Behandlung lymphoider Neoplasien. Klin Wochenschr 65, 247–252 (1987). https://doi.org/10.1007/BF01773441

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01773441

Key words

Search

Navigation